FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

10474911000001103: Sulfasalazine 500mg tablets 50 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
35859101000001118 Sulfasalazine 500mg tablets 50 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
35859201000001113 Sulfasalazine 500mg tablets 50 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sulfasalazine 500mg tablets 50 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Sulfasalazine 500mg tablets 50 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Sulfasalazine 500mg tablets 50 tablet Is pack of Product containing precisely sulfasalazine 500 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Sulfasalazine 500mg tablets 50 tablet Has active ingredient Bactericide false Inferred relationship Existential restriction modifier
Sulfasalazine 500mg tablets 50 tablet Has active ingredient Sulfasalazine false Inferred relationship Existential restriction modifier
Sulfasalazine 500mg tablets 50 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Sulfasalazine 500mg tablets 50 tablet Has active ingredient Substance with antibacterial mechanism of action false Inferred relationship Existential restriction modifier
Sulfasalazine 500mg tablets 50 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Sulfasalazine 500mg tablets 50 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Sulfasalazine 500mg tablets 50 tablet Has VMP Product containing precisely sulfasalazine 500 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Sulfasalazine 500mg tablets 50 tablet Has specific active ingredient Sulfasalazine true Inferred relationship Existential restriction modifier
Sulfasalazine 500mg tablets 50 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Salazopyrin 500mg tablets (PI) (Dowelhurst Ltd) 50 tablet Is a True Sulfasalazine 500mg tablets 50 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start